about
Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.Renal and vascular hypertension-induced inflammation: role of angiotensin II.TGF-beta signaling in vascular fibrosis.Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.Endothelial Notch1 Activity Facilitates Metastasis.Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.Notch controls endothelial cellsDown the liver sinusoidal endothelial cell (LSEC) hole. Is there a role for lipid rafts in LSEC fenestration?Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.Notch1 induces endothelial senescence and promotes tumor progression.MPDZ promotes DLL4-induced Notch signaling during angiogenesis.Notch signaling facilitates crossing of endothelial barriers by tumor cells.The Rho-kinase pathway regulates angiotensin II-induced renal damage.Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiationInhibitory effect of interleukin-1β on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cellsHMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular FibrosisAngiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle CellsOverexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibitionLoss of the serine protease HTRA1 impairs smooth muscle cells maturationMembrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor ProgressionFunctionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats
P50
Q33393631-C130EF5A-9F7A-47F7-9C63-7FA36CEF6457Q34144300-E7AF3126-65EE-4CA8-98EB-92CFDCBC58F7Q36398041-94E42E0B-69A9-4F24-B739-9E745BCE2F77Q36765987-284A520A-1401-4D6C-91A8-75F3A8DF0C3BQ38324521-625FFD98-C004-42F7-B412-2E7DB7507D08Q39855226-54A4C0D6-B92F-46CB-B3D8-E7B4ADD27CDCQ39960357-BF76037A-CA80-4DEE-94A1-1D58F3F56490Q40317866-92ED40FC-D63B-4351-BBFF-AD2267C6AD02Q41369308-AD91E2EF-1DDD-4BC5-A918-6459A7478F51Q42340853-D33D7C05-DCA0-4921-9E63-7EA5EBCD1DFAQ43967166-E5F73FF6-48B5-477E-AD42-5BE7CC64CF5DQ46481430-92D15814-7C03-4695-99E0-3B8E53E6A5EDQ48253445-5BD07EAC-11EF-4D99-AB2B-729B5B668DADQ52721396-ED11E4B9-7FEC-4AEF-B13A-533558BA6254Q53761712-2A99E8A4-B512-4F29-B0C6-13543F2110F6Q54627717-085682C4-F6FD-4324-8023-159AA79891E6Q61854900-9335D52A-117D-4AEB-B8B9-33FA2FAA0BF9Q61854905-3F2C3640-147A-4517-B36A-C3E216026284Q61854913-9457DC67-04A7-4297-A31F-0F483EC726F6Q61854944-87F094BB-FD8D-476A-936C-644A17DC5062Q87418312-22C1E065-5D3E-47DD-A234-BE7355AA9830Q91657393-5C5D28C0-3131-418E-916D-5AA83C9BF248Q92728069-7C4AF19E-FC31-4DC0-95BC-80A61D3C6825Q92984329-A368D2AA-B3E7-44B1-89AC-CADCCC54743C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9547-5508
@en
name
Juan Rodriguez-Vita
@ast
Juan Rodriguez-Vita
@de
Juan Rodriguez-Vita
@en
Juan Rodriguez-Vita
@es
Juan Rodriguez-Vita
@nl
type
label
Juan Rodriguez-Vita
@ast
Juan Rodriguez-Vita
@de
Juan Rodriguez-Vita
@en
Juan Rodriguez-Vita
@es
Juan Rodriguez-Vita
@nl
prefLabel
Juan Rodriguez-Vita
@ast
Juan Rodriguez-Vita
@de
Juan Rodriguez-Vita
@en
Juan Rodriguez-Vita
@es
Juan Rodriguez-Vita
@nl
P108
P227
P106
P108
P1153
8335679300
P21
P214
1574153289928932770008
P227
1163250325
P31
P496
0000-0001-9547-5508